Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Total 13F shares
-
48,764,141
-
Share change
-
+1,772,443
-
Total reported value
-
$1,672,916,979
-
Put/Call ratio
-
119%
-
Price per share
-
$34.32
-
Number of holders
-
160
-
Value change
-
+$32,659,099
-
Number of buys
-
86
-
Number of sells
-
80
Institutional Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q4 2018
As of 31 Dec 2018,
PTC THERAPEUTICS, INC. - Common Stock (PTCT) was held by
160 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
48,764,141 shares.
The largest 10 holders included
Vanguard Group Inc, BlackRock Inc., FRANKLIN RESOURCES INC, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, BOXER CAPITAL, LLC, RTW INVESTMENTS, LP, CITADEL ADVISORS LLC, and SCOPIA CAPITAL MANAGEMENT LP.
This page lists
160
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.